Inspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD

Respirology

Volumn 21, Issue 3, 2016, Pages 476-482

  Ramon, Maria A ^a,b,c   Ferrer, Jaume ^a,b,c   Gimeno Santos, Elena ^d,e,f   Donaire Gonzalez, David ^d,e,f   Rodríguez, Esther ^a,b,c   Balcells, Eva ^c,f,g   De Batlle, Jordi ^d,h   Benet, Marta ^d,e,f   Guerra, Stefano ^d,e,f   Sauleda, Jaume ⁱ   Ferrer, Antoni ^c,f,g,j   Farrero, Eva ^k,l   Gea, Joaquim ^c,f,g   Barberà, Joan A ^c,m   Agustí, Alvar ^c,m   Rodriguez Roisin, Robert ^c,m   Antó, Josep M ^d,e,f,g   Garcia Aymerich, Judith ^d,e,f  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

^g HOSPITAL DEL MAR   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^j UNIVERSITY OF BARCELONA   (Spain)

^k HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^l HOSPITAL DE SABADELL   (Spain)

^m INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

6 min walk distance; Chronic obstructive pulmonary disease; Cohort study; Disease progression; Exercise capacity

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EXERCISE; EXERCISE TEST; FEMALE; HEALTH STATUS; HUMAN; INSPIRATORY CAPACITY TO TOTAL LUNG CAPACITY RATIO; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WALKING; COMPLICATION; EXERCISE TOLERANCE; INSPIRATORY CAPACITY; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; TOTAL LUNG CAPACITY;

AGED; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; INSPIRATORY CAPACITY; LUNG; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOTAL LUNG CAPACITY;

EID: 84952815409     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12723     Document Type: Article

References (37)

1. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD-C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013; 188: e13-64.
2. Pepin V, Saey D, Laviolette L, Maltais F,. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD 2007; 4: 195-204.
3. Wijkstra PJ, TenVergert EM, van der Mark TW, Postma DS, Van Altena R, Kraan J, Koëter GH,. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax 1994; 49: 468-472.
4. Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PMA, Pinto-Plata V, Celli BR, Tal-Singer R, Wouters EFM,. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir. Med. 2010; 104: 849-857.
5. Oga T, Nishimura K, Tsukino M, Sato SHT,. Analysis of the factors related to mortality in chronic obstructive pulmonary disease role of exercise capacity and health status. Am. J. Respir. Crit. Care Med. 2003; 167: 544-549.
6. Jones PW,. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880-887.
7. Casanova C, Cote CG, Marin JM, de Torres JP, Aguirre-Jaime A, Mendez R, Dordelly L, Celli BR,. The 6-min walking distance: long-term follow up in patients with COPD. Eur. Respir. J. 2007; 29: 535-540.
8. Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR,. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007; 132: 1778-1785.
9. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M,. Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest 2005; 128: 62-69.
10. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR,. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur. Respir. J. 2004; 23: 28-33.
11. Casaburi R, ZuWallack R,. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N. Engl. J. Med. 2009; 360: 1329-1335.
12. Frisk B, Espehaug B, Hardie JA, Strand LI, Moe-Nilssen R, Eagan TML, Bakke PS, Thorsen E,. Physical activity and longitudinal change in 6-min walk distance in COPD patients. Respir. Med. 2014; 108: 86-94.
13. Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PMA, Tal-Singer R, Agusti A, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J. Am. Med. Dir. Assoc. 2012; 13: 291-297.
14. Hernán MA, Hernández-Díaz S, Robins JM,. A structural approach to selection bias. Epidemiology 2004; 15: 615-625.
15. Van Buuren S, Boshuizen HC, Knook DL,. Multiple imputation of missing blood pressure covariates in survival analysis. Stat. Med. 1999; 18: 681-694.
16. O'Donnell DE, Guenette JA, Maltais F, Webb KA,. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest 2012; 141: 753-762.
17. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR,. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 171: 591-597.
18. Tantucci C, Donati P, Nicosia F, Bertellaa E, Redolfia S, De Vecchia M, Cordaa L, Grassia V, Zullia R,. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respir. Med. 2008; 102: 613-619.
19. Diaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emil J, Lisboa C,. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur. Respir. J. 2000; 16: 269-275.
20. Albuquerque ALP, Nery LE, Villaça DS, Machado TYS, Oliveira CC, Paes AT, Neder JA,. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Eur. Respir. J. 2006; 28: 939-944.
21. Callens E, Graba S, Gillet-Juvin K, Essalhi M, Bidaud-Chevalier B, Peiffer C, Mahut B, Delclaux C,. Measurement of dynamic hyperinflation after a 6-minute walk test in patients with COPD. Chest 2009; 136: 1466-1472.
22. Garcia-Aymerich J, Gómez FP, Benet M, Farrero E, Basagaña X, Gayete À, Paré C, Freixa X, Ferrer J, Ferrer A, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66: 430-437.
23. Garcia-Aymerich J, Gómez FP, Antó JM,. Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD Study: design and methods. Arch. Bronconeumol. 2009; 45: 4-11.
24. Balcells E, Antó JM, Gea J, Gómez FP, Rodríguez E, Marin A, Ferrer A, de Batlle J, Farrero E, Benet M, et al. Characteristics of patients admitted for the first time for COPD exacerbation. Respir. Med. 2009; 103: 1293-1302.
25. Ramon MA, Gimeno-Santos E, Ferrer J, Balcells E, Rodríguez E, de Batlle J, Gómez FP, Sauleda J, Ferrer A, Barberà JA, et al. Hospital admissions and exercise capacity decline in patients with COPD. Eur. Respir. J. 2014; 43: 1018-1027.
26. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111-117.
27. Borg GA,. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 1982; 14: 377-381.
28. Ruppel GL,. Lung volumes and gas distribution tests. In:, Ruppel GL, (ed) Manual of Pulmonary Function Testing. Mosby, St Louis, MO, 1998; 69-94.
29. Celli BR, MacNee W,. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23: 932-946.
30. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013; 187: 347-365.
31. Rodríguez DA, Garcia-Aymerich J, Valera JL, Sauleda J, Togores B, Galdiz JB, Gea J, Orozco-Levi M, Ferrer A, Gomez FP, et al. Determinants of exercise capacity in obese and non-obese COPD patients. Respir. Med. 2014; 108: 745-751.
32. O'Donnell DE, Laveneziana P,. Dyspnea and activity limitation in COPD: mechanical factors. COPD 2007; 4: 225-236.
33. Guenette JA, Webb KA, O'Donnell DE,. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur. Respir. J. 2012; 40: 322-329.
34. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA,. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
35. Donders ART, van der Heijden GJMG, Stijnen T, Moons KGM,. Review: a gentle introduction to imputation of missing values. J. Clin. Epidemiol. 2006; 59: 1087-1091.
36. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ,. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005-1012.
37. Thomas M, Decramer M, Donnell DEO,. No room to breathe: the importance of lung hyperinflation in COPD. Prim. Care Respir. J. 2013; 22: 101-111.